Human hepatocellular carcinoma (HCC) is generally a highly vascular tumor, but the mechanisms of neovascularization that permit rapid growth have not been defined. Angiopoietins (Ang) recently have been identified as ligands for vascular endothelial-specific Tie2 receptor tyrosine kinase and may be important growth factors in the generation of new blood vessels. We investigated Ang expression in 23 samples of HCC and paired adjacent uninvolved liver samples to determine if these genes have a potential role in the growth and spread of this disease. The full coding sequence of a variant angiopoietin-2 (Ang2) cDNA was obtained from HCC specimens, and the biologic consequences of overexpression on tumor formation and hemorrhage were determined in an animal model system. Angiopoietin-1 (Ang1) was equally expressed in HCC and adjacent noncarcinomatous liver tissue. Surprisingly, Ang2 was found to be highly expressed only in tumor tissue. In addition, Ang2 was expressed in 10 of 12 hypervascular HCC, but only in 2 of 11 hypovascular HCC. Ectopic expression of Ang2 in nonexpressing HCC cells promotes the rapid development of human hepatomas and produces hemorrhage within tumors in nude mice. These results suggest a role for Ang2 in the neovascularization of HCC. This enhanced gene expression may contribute to the clinical hypervascular phenotype, as well as tumor formation and progression.
Shinji Tanaka, Masaki Mori, Yoshihiro Sakamoto, Masatoshi Makuuchi, Keizo Sugimachi, Jack R. Wands
Title and authors | Publication | Year |
---|---|---|
New insights into biomarkers and risk stratification to predict hepatocellular cancer
Li K, Mathew B, Saldanha E, Ghosh P, Krainer AR, Dasarathy S, Huang H, Xiang X, Mishra L |
Molecular Medicine | 2025 |
The clinical value of angiopoietin-2 in liver diseases.
Farshidpour M, Pace S, Volk ML |
Clinical Liver Disease | 2022 |
In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target
AM ten Voorde, AP Wierenga, RJ Nell, PA van der Velden, GP Luyten, RM Verdijk, MJ Jager |
Cancers | 2021 |
KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation
SA Scuderi, G Casili, A Ardizzone, S Forte, L Colarossi, S Sava, I Paterniti, E Esposito, S Cuzzocrea, M Campolo |
Cancers | 2021 |
Utility of serum neuropilin-1 and angiopoietin-2 as markers of hepatocellular carcinoma
MT Ghafar, RA Elkhouly, MH Elnaggar, MM Mabrouk, SA Darwish, RL Younis, RA Elkholy |
Journal of Investigative Medicine | 2021 |
Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
J Ao, T Chiba, H Kanzaki, K Kanayama, S Shibata, A Kurosugi, T Iwanaga, M Kan, T Sakuma, N Qiang, Y Ma, R Kojima, Y Kusakabe, M Nakamura, K Kobayashi, S Kiyono, N Kanogawa, T Saito, R Nakagawa, T Kondo, S Ogasawara, E Suzuki, S Nakamoto, R Muroyama, A Tawada, J Kato, T Kanda, H Maruyama, N Kato |
Journal of Cancer | 2021 |
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
B Vanderborght, S Lefere, HV Vlierberghe, L Devisscher |
Cells | 2020 |
Expression of Angiopoietins and Angiogenic Signaling Pathway Molecules in Chronic Subdural Hematomas
T Isaji, K Osuka, Y Ohmichi, M Ohmichi, M Naito, T Nakano, K Iwami, S Miyachi |
Journal of Neurotrauma | 2020 |
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
Kiss EA, Saharinen P |
Tumor Angiogenesis | 2019 |
Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology
S Tanaka |
Annals of Gastroenterological Surgery | 2018 |
The Role of Angiogenesis in Colorectal Polyps and Cancer, a Review
HA Aghdaei, Z Pezeshkian, M Abdollahpour-Alitappeh, EN Mojarad, MR Zali |
2018 | |
Tumor Angiogenesis: A Key Target for Cancer Therapy
D Marmé |
Tumor Angiogenesis | 2018 |
Advances in genomic hepatocellular carcinoma research
W Huang, AJ Skanderup, CG Lee |
GigaScience | 2018 |
Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
RC Pestana, MM Hassan, R Abdel-Wahab, YI Abugabal, LM Girard, D Li, P Chang, K Raghav, J Morris, RA Wolff, A Rashid, HM Amin, A Kaseb |
Oncotarget | 2018 |
Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
K Angara, TF Borin, AS Arbab |
Translational oncology | 2017 |
Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems
Á Hernández-Bartolomé, R López-Rodríguez, L García-Buey, S Martín-Vílchez, Y Rodríguez-Muñoz, MJ Borque, L González-Moreno, Y Real-Martínez, J Mendoza-Ridruejo, E Martín-Pérez, R Moreno-Otero, P Sanz-Cameno |
Liver International | 2017 |
Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms
FP Cantatore, N Maruotti, A Corrado, D Ribatti |
BioMed Research International | 2017 |
Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease
KG Blecharz, D Frey, T Schenkel, V Prinz, G Bedini, SM Krug, M Czabanka, J Wagner, M Fromm, A Bersano, P Vajkoczy |
Journal of Cerebral Blood Flow & Metabolism | 2016 |
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
A Kaseb, J Morris, M Iwasaki, H Al-Shamsi, K Raghav, L Girard, S Cheung, V Nguyen, K Elsayes, L Xiao, R Abdel-Wahab, A Shalaby, M Hassan, H Hassabo, R Wolff, J Yao |
OncoTargets and therapy | 2016 |
Infectious Angiogenesis—Different Pathways, the Same Goal:
M Urbanowicz, H Kutzner, E Riveiro-Falkenbach, JL Rodriguez-Peralto |
The American Journal of Dermatopathology | 2016 |
Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease
KG Blecharz, D Frey, T Schenkel, V Prinz, G Bedini, SM Krug, M Czabanka, J Wagner, M Fromm, A Bersano, P Vajkoczy |
Journal of Cerebral Blood Flow & Metabolism | 2016 |
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, G Cabibbo, M Enea, S Colopi, C Caporali, T Pollicino, F Milosa, A Karampatou, P Todesca, E Bertolini, L Maccio, ML Martinez-Chantar, E Turola, MD Buono, ND Maria, S Ballestri, F Schepis, P Loria, GE Gerunda, L Losi, U Cillo |
Gut | 2015 |
Chesley's Hypertensive Disorders in Pregnancy
SJ Fisher, M McMaster, JM Roberts |
Chesley's Hypertensive Disorders in Pregnancy | 2015 |
Role of Angiopoietin-2 in Corneal Lymphangiogenesis
D Yuen, S Grimaldo, R Sessa, T Ecoiffier, T Truong, E Huang, M Bernas, S Daley, M Witte, L Chen |
Investigative ophthalmology & visual science | 2014 |
PHIPing Out: A Genetic Basis for Tumor Ulceration
JL Arbiser |
Journal of Investigative Dermatology | 2014 |
Effect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma growth
HH Chen, BQ Weng, KJ Cheng, HY Liu, SQ Wang, YY Lu |
Vascular cell | 2014 |
Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma: Angiogenesis in HCC Patients
RM Talaat, TA Salem, S El-Masry, A Imbarek, M Mokhles, A Abdel-Aziz |
Journal of Medical Virology | 2014 |
Overexpression of angiopoietin-2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition
M Pauta, J Ribera, P Melgar-Lesmes, G Casals, J Rodríguez-Vita, V Reichenbach, G Fernandez-Varo, B Morales-Romero, R Bataller, J Michelena, J Altamirano, W Jiménez, M Morales-Ruiz |
Liver International | 2014 |
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
A Kaseb, F Janku, M Bupathi |
OncoTargets and therapy | 2014 |
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
K Miyahara, K Nouso, Y Morimoto, Y Takeuchi, H Hagihara, K Kuwaki, H Onishi, F Ikeda, Y Miyake, S Nakamura, H Shiraha, A Takaki, M Honda, S Kaneko, T Sato, S Sato, S Obi, S Iwadou, Y Kobayashi, K Takaguchi, K Kariyama, Y Takuma, H Takabatake, K Yamamoto, K Yamamoto, Y Morimoro, Y Takeuchi, K Miyahara, H Hagihara, K Kuwaki, H Onishi, S Nakamura, H Shiraha, K Nouso, Y Takuma, H Takabatake, Y Morimoto, S Fujioka, T Osawa, K Kariyama, J Toshimori, H Kobashi, H Miyatake, S Iwadou, Y Kobayashi, S Uematsu, R Okamoto, Y Araki, M Tatsukawa, K Yabushita, T Shimoe, K Sakaguchi, T Sakata, T Kaneyoshi, M Miyashita, Y Makino, A Moriya, M Ando, N Baba, T Seno, T Nagano, K Takaguchi, E Matsumoto, H Takayama |
British Journal of Cancer | 2013 |
Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma
C Li, C Sun, J Fan, N Geng, C Li, J Liao, K Mi, G Zhu, H Ma, Y Song, Y Tang, Y Chen |
Medical Oncology | 2013 |
Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma
A Diaz-Sanchez, A Matilla, O Nuñez, R Lorente, A Fernandez, D Rincón, R Campos, R Bañares, G Clemente |
Scandinavian Journal of Gastroenterology | 2013 |
Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
T Li, Z Liu, K Jiang, Q Ruan |
Cancer Letters | 2013 |
Putative effects of potentially anti-angiogenic drugs in rheumatic diseases
N Maruotti, FP Cantatore, D Ribatti |
European Journal of Clinical Pharmacology | 2013 |
Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link
A Hernández-Bartolomé, R López-Rodríguez, Y Rodríguez-Muñoz, S Martín-Vílchez, MJ Borque, L García-Buey, L González-Moreno, Y Real, R Moreno-Otero, P Sanz-Cameno |
PloS one | 2013 |
Gene expression of growth factors and growth factor receptors for potential targeted therapy of canine hepatocellular carcinoma
G Iida, K Asano, M Seki, M Sakai, K Kutara, K Ishigaki, Y Kagawa, O Yoshida, K Teshima, K Edamura, T Watari |
Journal of Veterinary Medical Science | 2013 |
Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link
Á Hernández-Bartolomé, R López-Rodríguez, Y Rodríguez-Muñoz, S Martín-Vílchez, MJ Borque, L García-Buey, L González-Moreno, Y Real, R Moreno-Otero, P Sanz-Cameno, JP Vartanian |
PloS one | 2013 |
Adenoviral gene therapy in hepatocellular carcinoma: a review
I Lyra-González, LE Flores-Fong, I González-García, D Medina-Preciado, J Armendáriz-Borunda |
Hepatology International | 2012 |
Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications
C Frenette, R Gish |
World journal of gastroenterology : WJG | 2012 |
Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma: DCP and tumor angiogenesis in HCC
M Matsubara, H Shiraha, J Kataoka, M Iwamuro, S Horiguchi, S Nishina, N Takaoka, M Uemura, A Takaki, S Nakamura, Y Kobayashi, K Nouso, K Yamamoto |
Journal of Gastroenterology and Hepatology | 2012 |
Tie2-Dependent Neovascularization of the Ischemic Hindlimb Is Mediated by Angiopoietin-2
M Lekas, P Lekas, SH Mei, Y Deng, DJ Dumont, DJ Stewart |
PloS one | 2012 |
Source of angiopoietin-2 in the sera of women during pregnancy
C Woolnough, Y Wang, CY Kan, JM Morris, V Tasevski, AW Ashton |
Microvascular Research | 2012 |
Molecular Targeted Therapies in Hepatocellular Carcinoma
S Tanaka, S Arii |
Seminars in Oncology | 2012 |
Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies
S Tanaka, S Arii |
Journal of Gastroenterology | 2011 |
Angiopoietin-2 inhibits the growth of tongue carcinoma without affecting expression of vascular endothelial growth factor
H Chen, L Chai, S Wang, Z Shi, Q Wu |
International Journal of Oral and Maxillofacial Surgery | 2011 |
AMG 386: profile of a novel angiopoietin antagonist in patients with ovarian cancer
EJ Robson, P Ghatage |
Expert Opinion on Investigational Drugs | 2011 |
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives
YC Shen, C Hsu, AL Cheng |
Journal of Gastroenterology | 2010 |
HCV-related hepatocellular carcinoma: From chronic inflammation to cancer
G Castello, S Scala, G Palmieri, SA Curley, F Izzo |
Clinical Immunology | 2010 |
Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT)
L Ojeda-Fernandez, L Barrios, A Rodriguez-Barbero, L Recio-Poveda, C Bernabeu, LM Botella |
Clinica Chimica Acta | 2010 |
Chemotherapy with PLGA microspheres containing docetaxel decreases angiogenesis in human hepatoma xenograft
Z Chen, M Cai, J Yang, L Lin, E Xue, J Huang, H Wei, X Zhang, L Ke |
Medical Oncology | 2010 |
Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas
S Tanaka, K Mogushi, M Yasen, N Noguchi, A Kudo, N Nakamura, K Ito, Y Miki, J Inazawa, H Tanaka, S Arii |
Surgery | 2010 |
Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science
S Tanaka, S Arii |
International Journal of Clinical Oncology | 2010 |
Hepatitis B virus/hepatitis C virus upregulate angiopoietin-2 expression through mitogen-activated protein kinase pathway: HBV/HCV promotes Ang-2 expression via MAPK pathway
Y Li, J Chen, C Wu, L Wang, M Lu, X Chen |
Hepatology Research | 2010 |
Hepatocellular Carcinoma:
KM McMasters |
2010 | |
Genetic and epigenetic silencing of SCARA5 may contribute to hepatocellular carcinoma by activating FAK signaling
Jian Huang, DaLi Zheng, Feng-Song Qin, Na Cheng, Hui Chen, Yu-Ping WANG, BinBin Wan, Hua-Sheng Xiao, Ze-Guang Han |
Journal of Clinical Investigation | 2009 |
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
M Mejias, E Garcia-Pras, C Tiani, R Miquel, J Bosch, M Fernandez |
Hepatology | 2009 |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler |
2009 | |
Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells
H Wada, H Nagano, H Yamamoto, T Noda, M Murakami, S Kobayashi, S Marubashi, H Eguchi, Y Takeda, M Tanemura, K Umeshita, Y Doki, M Mori |
BMC Cancer | 2009 |
Cerebral arteriovenous malformations. Part 1: cellular and molecular biology
P Moftakhar, JS Hauptman, D Malkasian, NA Martin |
Neurosurgical FOCUS | 2009 |
The effects of angiopoietin-2 on the growth of tongue carcinoma
Chen, Z Shi, S Wang, Q Wu |
British Journal of Oral and Maxillofacial Surgery | 2009 |
Angiogenesis and Preeclampsia
SA Karumanchi, IE Stillman, MD Lindheimer |
Chesley s Hypertensive Disorders in Pregnancy | 2009 |
Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways
M Hassan, D Selimovic, H Ghozlan, O Abdel-kader |
Hepatology | 2009 |
The role of the Angiopoietins in vascular morphogenesis
M Thomas, HG Augustin |
Angiogenesis | 2009 |
Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2
Y Reiss, A Knedla, AO Tal, MH Schmidt, M Jugold, F Kiessling, AM Burger, H Wolburg, U Deutsch, KH Plate |
The Journal of Pathology | 2009 |
Serum Levels of Angiopoietin-1, Angiopoietin-2, and Their Receptor Tie-2 in Patients with Nonsmall Cell Lung Cancer During Chemotherapy
W Naumnik, E Chyczewska, M Ossolinska |
Cancer Investigation | 2009 |
The Opening Act: Vasculogenesis and the Origins of Circulation
SW Jin, C Patterson |
Arteriosclerosis, thrombosis, and vascular biology | 2009 |
CNS Cancer
EG Meir |
2009 | |
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
K Taura, SD Minicis, E Seki, E Hatano, K Iwaisako, CH Osterreicher, Y Kodama, K Miura, I Ikai, S Uemoto, DA Brenner |
Gastroenterology | 2008 |
Application of angiogenesis to clinical dermatology
LE Fried, JL Arbiser |
Advances in Dermatology | 2008 |
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy
S Tanaka, S Arii, M Yasen, K Mogushi, NT Su, C Zhao, I Imoto, Y Eishi, J Inazawa, Y Miki, H Tanaka |
British Journal of Surgery | 2008 |
Molecularly targeted therapy for hepatocellular carcinoma
S Tanaka, S Arii |
Kanzo | 2008 |
Insulin-like growth factors, angiopoietin-2, and pigment epithelium–derived growth factor in the hypoxic retina
V Sivakumar, Y Zhang, EA Ling, WS Foulds, C Kaur |
Journal of Neuroscience Research | 2008 |
Inhibition of In Vivo Tumor Angiogenesis and Growth Via Systemic Delivery of an Angiopoietin 2-Specific RNA Aptamer
S Sarraf-Yazdi, J Mi, BJ Moeller, X Niu, RR White, CD Kontos, BA Sullenger, MW Dewhirst, BM Clary |
Journal of Surgical Research | 2008 |
The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization
W Zeng, AS Gouw, MC van Heuvel, PJ Zwiers, PE Zondervan, S Poppema, N Zhang, I Platteel, KP de Jong, G Molema |
Hepatology | 2008 |
Pelioid-type hepatocellular carcinoma with numerous eosinophilic infiltrations in a patient with primary biliary cirrhosis
T Watanabe, K Aikawa, T Kanefuji, K Yamazaki, H Hirono, K Hasegawa, K Soga, K Shibasaki, H Umezu, M Nomoto |
Hepatology Research | 2008 |
Vascular Changes in Hepatocellular Carcinoma
ZF Yang, RT Poon |
The Anatomical Record Advances in Integrative Anatomy and Evolutionary Biology | 2008 |
Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma
S Kuboki, H Shimizu, N Mitsuhashi, K Kusashio, F Kimura, H Yoshidome, M Ohtsuka, A Kato, H Yoshitomi, M Miyazaki |
Journal of Gastroenterology and Hepatology | 2008 |
Antiangiogenic Agents in Cancer Therapy
BA Teicher, LM Ellis |
2008 | |
Quantum Dot Self-Assembly for Protein Detection with Sub-Picomolar Sensitivity
CP Soman, TD Giorgio |
Langmuir | 2008 |
Why targeted therapy hasn’t worked in advanced cancer
Jack L. Arbiser |
Journal of Clinical Investigation | 2007 |
Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1
FC Ye, DJ Blackbourn, M Mengel, JP Xie, LW Qian, W Greene, IT Yeh, D Graham, SJ Gao |
Journal of virology | 2007 |
Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2
VP Nguyen, SH Chen, J Trinh, H Kim, BL Coomber, DJ Dumont |
BMC cell biology | 2007 |
Perspectives in Medical Virology
KD Mena |
Perspectives in Medical Virology | 2007 |
Molecular targeted therapy for advanced hepatocellular carcinoma
YC Shen, C Hsu, AL Cheng |
Targeted Oncology | 2007 |
Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis: MicroRNA in HCC
YS Huang, Y Dai, XF Yu, SY Bao, YB Yin, M Tang, CX Hu |
Journal of Gastroenterology and Hepatology | 2007 |
Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges
Y Midorikawa, M Makuuchi, W Tang, H Aburatani |
World journal of gastroenterology : WJG | 2007 |
Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions
H Tomimoto, S Yano, H Muguruma, S Kakiuchi, S Sone |
The Journal of Medical Investigation | 2007 |
From Molecular Biology to Targeted Therapies for Hepatocellular Carcinoma: The Future Is Now
RW Pang, RT Poon |
Oncology | 2007 |
Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein
P Sanz-Cameno, S Martín-Vílchez, E Lara-Pezzi, MJ Borque, J Salmerón, PM de Rueda, JA Solís, M López-Cabrera, R Moreno-Otero |
The American Journal of Pathology | 2006 |
Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma
S Tanaka, S Arii |
International Journal of Clinical Oncology | 2006 |
Pharmacologic Blockade of Angiopoietin-2 Is Efficacious against Model Hemangiomas in Mice
BN Perry, B Govindarajan, SS Bhandarkar, UG Knaus, M Valo, C Sturk, CO Carrillo, A Sohn, F Cerimele, D Dumont, A Losken, J Williams, LF Brown, X Tan, E Ioffe, GD Yancopoulos, JL Arbiser |
Journal of Investigative Dermatology | 2006 |
Specific Peptide Ligand for Grb7 Signal Transduction Protein and Pancreatic Cancer Metastasis
S Tanaka, SC Pero, K Taguchi, M Shimada, M Mori, DN Krag, S Arii |
JNCI Journal of the National Cancer Institute | 2006 |
Viral hepatitis and liver cancer: the case of hepatitis C
M Levrero |
Oncogene | 2006 |
A Comparison of Antiangiogenic Therapies for the Prevention of Liver Metastases
J Mi, S Sarraf-Yazdi, X Zhang, Y Cao, MW Dewhirst, CD Kontos, CY Li, BM Clary |
Journal of Surgical Research | 2006 |
Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents
CI Calfa, JD Rosenblatt, HM Cho, K Webster, SU Shin |
Update on cancer therapeutics | 2006 |
Induction of Angiopoietin-2 gene expression by COX-2: A novel role for COX-2 inhibitors during hepatocarcinogenesis
S Tanaka, JR Wands, S Arii |
Journal of Hepatology | 2006 |
Gene expressions of canine angiopoietin-1 and -2 in normal tissues and spontaneous tumours
Y Kato, K Asano, I Mizutani, T Konno, Y Sasaki, K Kutara, K Teshima, K Edamura, R Kano, K Suzuki, H Shibuya, T Sato, A Hasegawa, S Tanaka |
Research in Veterinary Science | 2006 |
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma
D Ribatti, A Vacca, B Nico, D Sansonno, F Dammacco |
Cancer Treatment Reviews | 2006 |
Transgenic expression of Angiopoietin 1 in the liver leads to changes in lymphatic and blood vessel architecture
AL Haninec, D Voskas, A Needles, AS Brown, FS Foster, DJ Dumont |
Biochemical and Biophysical Research Communications | 2006 |
The Duality of Angiogenesis: Implications for Therapy of Human Disease
BN Perry, JL Arbiser |
Journal of Investigative Dermatology | 2006 |
Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors
H Kumamoto, K Ooya |
Journal of Oral Pathology and Medicine | 2006 |
Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
R Pang, RT Poon |
Cancer Letters | 2006 |
Chronic systemic delivery of angiopoietin-2 reveals a possible independent angiogenic effect
W Bureau, PV Slyke, J Jones, RN Han, NL Ward, DJ Stewart, DJ Dumont |
American journal of physiology. Heart and circulatory physiology | 2006 |
Hepatic Tumor Growth: Target for Angiogenesis Inhibition?
S Sarraf-Yazdi, J Mi, BM Clary |
World Journal of Surgery | 2005 |
Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice
H Yoshiji, S Kuriyama, R Noguchi, J Yoshii, Y Ikenaka, K Yanase, T Namisaki, M Kitade, M Uemura, T Masaki, H Fukui |
Gut | 2005 |
Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma
H Iida, M Honda, HF Kawai, T Yamashita, Y Shirota, BC Wang, H Miao, S Kaneko |
Gut | 2005 |
Pathophysiology of tumor neovascularization
M Furuya, M Nishiyama, Y Kasuya, S Kimura, H Ishikura |
Vascular Health and Risk Management | 2005 |
The Role of Angiopoietins During Angiogenesis in Gliomas
Y Reiss, MR Machein, KH Plate |
Brain Pathology | 2005 |
Angiopoietin-1 and Myeloma-Induced Angiogenesis
N Giuliani, S Colla, F Morandi, V Rizzoli |
Leukemia & Lymphoma | 2005 |
Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization
N Singh, E Macnamara, S Rashid, J Ambati, CD Kontos, E Higgins, BK Ambati |
Biochemical and Biophysical Research Communications | 2005 |
The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells
C Harada, Y Mitamura, T Harada |
Progress in Retinal and Eye Research | 2005 |
Review article: angiogenesis soluble factors as liver disease markers
X Salcedo, J Medina, P Sanz-Cameno, L Garcia-Buey, S Martin-Vilchez, R Moreno-Otero |
Alimentary Pharmacology & Therapeutics | 2005 |
Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer
N Oka, Y Yamamoto, M Takahashi, M Nishitani, HO Kanayama, S Kagawa |
BJU International | 2005 |
Pathogenesis of hepatocellular carcinoma:
D Moradpour, HE Blum |
European Journal of Gastroenterology & Hepatology | 2005 |
Anti-Angiogenic Treatment of Gastrointestinal Malignancies
JS Salmon, AC Lockhart, J Berlin |
Cancer Investigation | 2005 |
Absence of Smooth Muscle Actin-Positive Pericyte Coverage of Tumor Vessels Correlates with Hematogenous Metastasis and Prognosis of Colorectal Cancer Patients
Y Yonenaga, A Mori, H Onodera, S Yasuda, H Oe, A Fujimoto, T Tachibana, M Imamura |
Oncology | 2005 |
Hepatocellular Cancer
BI Carr |
2005 | |
Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease
NL Ward, AL Haninec, PV Slyke, JG Sled, C Sturk, RM Henkelman, IR Wanless, DJ Dumont |
The American Journal of Pathology | 2004 |
The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors
P Hildbrand, V Cirulli, RC Prinsen, KA Smith, BE Torbett, DR Salomon, L Crisa |
Blood | 2004 |
Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
T Torimura, T Ueno, M Kin, R Harada, E Taniguchi, T Nakamura, R Sakata, O Hashimoto, M Sakamoto, R Kumashiro, M Sata, O Nakashima, H Yano, M Kojiro |
Journal of Hepatology | 2004 |
Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model
MR Machein, A Knedla, R Knoth, S Wagner, E Neuschl, KH Plate |
The American Journal of Pathology | 2004 |
Hepatic expression ofANG2 RNA in metastatic colorectal cancer
M Ogawa, H Yamamoto, H Nagano, Y Miyake, Y Sugita, T Hata, B Kim, CY Ngan, B Damdinsuren, M Ikenaga, M Ikeda, M Ohue, S Nakamori, M Sekimoto, M Sakon, N Matsuura, M Monden |
Hepatology | 2004 |
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
J Oliner, H Min, J Leal, D Yu, S Rao, E You, X Tang, H Kim, S Meyer, SJ Han, N Hawkins, R Rosenfeld, E Davy, K Graham, F Jacobsen, S Stevenson, J Ho, Q Chen, T Hartmann, M Michaels, M Kelley, L Li, K Sitney, F Martin, JR Sun, N Zhang, J Lu, J Estrada, R Kumar, A Coxon, S Kaufman, J Pretorius, S Scully, R Cattley, M Payton, S Coats, L Nguyen, B Desilva, A Ndifor, I Hayward, R Radinsky, T Boone, R Kendall |
Cancer Cell | 2004 |
Pathobiology of Human Cerebrovascular Malformations: Basic Mechanisms and Clinical Relevance
J Gault, H Sarin, NA Awadallah, R Shenkar, IA Awad |
Neurosurgery | 2004 |
Role of vascular endothelial growth factor on the invasive potential of hepatocellular carcinoma
S Arii |
Journal of Hepatology | 2004 |
Autocrine/paracrine role of the angiopoietin-1 and -2/Tie2 system in cell proliferation and chemotaxis of cultured fibroblastic synoviocytes in rheumatoid arthritis
K Takahara, T Iioka, K Furukawa, T Uchida, M Nakashima, T Tsukazaki, H Shindo |
Human Pathology | 2004 |
Identification of Molecular Markers Specific for Pancreatic Neuroendocrine Tumors by Genetic Profiling of Core Biopsies
M Bloomston, A Durkin, I Yang, M Rojiani, AS Rosemurgy, S Enkmann, TJ Yeatman, EE Zervos |
Annals of Surgical Oncology | 2004 |
Role of Ang1 and Its Interaction with VEGF-A in Astrocytomas
G Zadeh, K Koushan, L Pillo, P Shannon, A Guha |
Journal of Neuropathology and Experimental Neurology | 2004 |
Expression and significance of angiopoietin-2 in gastric cancer
Xiao-Dong Sun, Xing-E Liu, Jin-Min Wu, Xiu-Jun Cai, Yi-Ping Mou, Jun-Da Li |
World journal of gastroenterology : WJG | 2004 |
Mathematical modeling of tumor-induced angiogenesis
NV Mantzaris, S Webb, HG Othmer |
Journal of Mathematical Biology | 2004 |
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives
HC Sun, ZY Tang |
Journal of Cancer Research and Clinical Oncology | 2004 |
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2
RR White, S Shan, CP Rusconi, G Shetty, MW Dewhirst, CD Kontos, BA Sullenger |
Proceedings of the National Academy of Sciences | 2003 |
Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells
J Pomyje, J Zivny, L Sefc, M Plasilova, R Pytlik, E Necas |
European Journal of Haematology | 2003 |
Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor
F Cerimele, LF Brown, F Bravo, GM Ihler, P Kouadio, JL Arbiser |
The American Journal of Pathology | 2003 |
Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma
K Sugimachi, S Tanaka, K Taguchi, S Aishima, M Shimada, M Tsuneyoshi |
Journal of clinical pathology | 2003 |
Angiopoietins in angiogenesis and beyond
S Tsigkos, M Koutsilieris, A Papapetropoulos |
Expert Opinion on Investigational Drugs | 2003 |
Not just angiogenesis?wider roles for the angiopoietins
PF Jones |
The Journal of Pathology | 2003 |
Gene Therapy for Hepatocellular Carcinoma
PY Lam |
Cancer Reviews: Asia-Pacific | 2003 |
The Kidney
LM Satlin, CB Woda, GJ Schwartz |
The Kidney | 2003 |
Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells
N Giuliani, S Colla, M Lazzaretti, R Sala, G Roti, C Mancini, S Bonomini, P Lunghi, M Hojden, G Genestreti, M Svaldi, P Coser, PP Fattori, G Sammarelli, GC Gazzola, R Bataille, C Almici, C Caramatti, L Mangoni, V Rizzoli |
Haematologica | 2003 |
Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells
N Giuliani, S Colla, M Lazzaretti, R Sala, G Roti, C Mancini, S Bonomini, P Lunghi, M Hojden, G Genestreti, M Svaldi, P Coser, PP Fattori, G Sammarelli, GC Gazzola, R Bataille, C Almici, C Caramatti, L Mangoni, V Rizzoli |
Haematologica | 2003 |
Reversing the Angiogenic Switch with Photodynamic Therapy
JL Arbiser |
Journal of Investigative Dermatology | 2003 |
Expression of Tie-2 in human peripheral and autonomic nervous system
S Poncet, JM Gasc, RC Janzer, S Meyer, L Juillerat-Jeanneret |
Neuropathology and Applied Neurobiology | 2003 |
Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma
N Mitsuhashi |
Hepatology | 2003 |
Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma
S Tanaka, K Sugimachi, YY Yi, T Ohga, K Shirabe, M Shimada, JR Wands, K Sugimachi |
Hepatology | 2002 |
Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1
S Tian, AJ Hayes, LJ Metheny-Barlow, LY Li |
British Journal of Cancer | 2002 |
Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast
A Rice, CM Quinn |
Journal of clinical pathology | 2002 |
Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth
T Hawighorst, M Skobe, M Streit, YK Hong, P Velasco, LF Brown, L Riccardi, B Lange-Asschenfeldt, M Detmar |
The American Journal of Pathology | 2002 |
Extensive Oligonucleotide Microarray Transcriptome Analysis of the Rat Cerebral Artery and Arachnoid Tissue
H Wada, K Hashimoto, Y Wada, M Kobayashi, A Izumi, A Sugiyama, T Kohro, T Hamakubo, T Kodama |
Journal of Atherosclerosis and Thrombosis | 2002 |
Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma
S Tanaka, K Sugimachi, S Maehara, N Harimoto, K Shirabe, JR Wands, K Sugimachi |
Surgery | 2002 |
The mechanisms of angiogenesis in hepatocellular carcinoma: Angiogenic switch during tumor progression
K Sugimachi, S Tanaka, T Terashi, K Taguchi, T Rikimaru, K Sugimachi |
Surgery | 2002 |
Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells
YQ Huang, JJ Li, L Hu, M Lee, S Karpatkin |
Blood | 2002 |
Regulation of angiopoietin and Tie-2 receptor expression in non-reproductive tissues by estrogen
F Ye, M Florian, SA Magder, SN Hussain |
Steroids | 2002 |
Hepatocellular carcinoma--cause, treatment and metastasis
Z Y Tang |
World journal of gastroenterology : WJG | 2002 |
Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen
D Ganten, K Ruckpaul, SA Hahn, W Schmiegel |
2002 | |
Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn
Y Mochizuki, T Nakamura, H Kanetake, S Kanda |
Journal of cell science | 2002 |
Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells
Y Yu, J Varughese, LF Brown, JB Mulliken, J Bischoff |
The American Journal of Pathology | 2001 |
Angiopoietin-1, angiopoietin-2 and Tie-2 in tumour and non-tumour tissues during growth of experimental melanoma
J Pomyje, JH Živný, T Stopka, J Šimák, H Vaňková, E Nečas |
Melanoma Research | 2001 |
Inhibition of angiopoietin-1 expression in tumor cells by an antisense RNA approach inhibited xenograft tumor growth in immunodeficient mice
WS Shim, M Teh, PO Mack, R Ge |
International Journal of Cancer | 2001 |
Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells
A Otani, H Takagi, H Oh, S Koyama, Y Honda |
Diabetes | 2001 |
Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma
C Libo, Y Zhen, W Guobin, W Chunyou |
Journal of Tongji Medical University | 2001 |
Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma: A possible mechanism for the initiation of angiogenesis
SA Ahmad, W Liu, YD Jung, F Fan, N Reinmuth, CD Bucana, LM Ellis |
Cancer | 2001 |
Hepatocellular Carcinoma-Cause, Treatment and Metastasis
ZY Tang |
World journal of gastroenterology : WJG | 2001 |
Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats
K Abdulmalek, F Ashur, N Ezer, F Ye, S Magder, SN Hussain |
American journal of physiology. Lung cellular and molecular physiology | 2001 |
Tumor Angiogenesis
M Detmar |
Journal of Investigative Dermatology Symposium Proceedings | 2000 |
Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells
HT Yuan, SP Yang, AS Woolf |
Kidney International | 2000 |
Angiopoietin/Tie receptor system: emerging targets for therapeutic angiogenesis and anti-angiogenic therapy
G Siemeister |
Expert Opinion on Therapeutic Targets | 2000 |
Is angiogenesis inhibition the Holy Grail of cancer therapy?
T Boehm-Viswanathan |
Current Opinion in Oncology | 2000 |
The discovery of angiogenic factors:
D Ribatti, A Vacca, M Presta |
General Pharmacology: The Vascular System | 2000 |
New molecular mediators in tumor angiogenesis
WD Beecken, W Kramer, D Jonas |
Journal of Cellular and Molecular Medicine | 2000 |
Tumor Necrosis Factor-α Upregulates Angiopoietin-2 in Human Umbilical Vein Endothelial Cells
I Kim, JH Kim, YS Ryu, M Liu, GY Koh |
Biochemical and Biophysical Research Communications | 2000 |
The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas
MP Wong, SY Chan, KH Fu, SY Leung, N Cheung, ST Yuen, LP Chung |
Lung Cancer | 2000 |
Characterization and Expression of a Novel Alternatively Spliced Human Angiopoietin-2
I Kim, JH Kim, YS Ryu, SH Jung, JJ Nah, GY Koh |
The Journal of biological chemistry | 2000 |
Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
I Kim, JH Kim, SO Moon, HJ Kwak, NG Kim, GY Koh |
Oncogene | 2000 |
Angiopoietin-2 Is a Site-Specific Factor in Differentiation of Mouse Renal Vasculature
HT Yuan, C Suri, DA Landon, GD Yancopoulos, AS Woolf |
Journal of the American Society of Nephrology : JASN | 2000 |
Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas
LJ Metheny-Barlow, LY Li |
Clinical cancer research | 1999 |
The role of the vascular phase in solid tumor growth: a historical review
D Ribatti, A Vacca, F Dammacco |
Neoplasia (New York, N.Y.) | 1999 |
Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas
LJ Metheny-Barlow, LY Li |
Clinical cancer research | 1999 |